Navigation Links
Professor Wing Wong Elected to the National Academy of Sciences
Date:5/18/2009

aTyr Pharma Scientific Advisory Board Member Recognized for Development of Statistical Methods and Software

SAN DIEGO, May 18 /PRNewswire/ -- Wing Hung Wong, Professor of Statistics and of Health Research & Policy at Stanford University has been elected to the US National Academy of Sciences. Election to the National Academy of Sciences is one of the highest honors that can be accorded to a scientist in the US and this honor recognizes Professor Wong's significant contributions in developing statistical methods and software for analyzing complex databases, such as those from high throughput genomics research.

With over 100 publications in peer reviewed journals, Professor Wong has developed ground-breaking methods for turning large data sets into useful information about biological systems. His contributions to biological advancements through computational analysis are many, and include methods and algorithms for the analysis of gene expression data from microarray chips, identification of gene regulatory elements in developmental genomics, and elucidation of genetic networks.

According to Professor Paul Schimmel, co-founder of aTyr Pharma and fellow NAS member: "We are pleased to see this well deserved recognition of Professor Wong's valuable contributions to computational analysis of complex biological data. As a member of our scientific advisory board, Professor Wong has provided invaluable guidance for building aTyr's platform of naturally occurring, therapeutic splice variants of human tRNA synthetases. His work with genomics data has accelerated understanding of biology and paved the way for significant health advances." aTyr Pharma congratulates Professor Wong on this well deserved honor.

    Company Contact:                          Media Contact:
    Cheryl Quinn                              Jennifer James
    Director of Business Development          Alta Partners
    aTyr Pharma                               (415) 362-4022
    858-731-8390                              jjames@altapartners.com
    cquinn@atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team
2. University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference
3. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award
4. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes, Jr. Award
5. Professor K. C. Nicolaou Speaks at WuXi AppTec
6. Nyenrode Honorary Doctorate for Professor Michael E. Porter
7. Thin films research lands engineering professor Air Force Young Investigator Award
8. Gift Aids Professor's Research into Vein Treatment
9. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
10. UCF professor develops vaccine to protect against black plague bioterror attack
11. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... the Life -Sciences division, Treximo will pair its $200M operational capacity with ... consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017   ... US, an international IT solutions and managed services provider ... offering – Service Desk for Epic. The new service ... their internal Epic resources by giving physicians, nurses and ... IT specialists for tier-one support. This will allow hospital ...
(Date:2/20/2017)... MONTREAL , Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... as President and CEO and Fabrice Orecchioni, the company,s COO, has ... as COO over the past four years, Fabrice has overseen the ... Sarnia and the management of the Mitsui JV.  Fabrice ... for the proposed China JV. ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
Breaking Biology News(10 mins):